News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
How Much Rumored Suitors Like Sanofi Would Have To Pay For Sarepta
May 2, 2017
·
1 min read
Deals
Why M&A Hungry Sanofi Could be Gearing Up to Buy Sarepta
May 1, 2017
·
2 min read
Genetown
Here’s Why Sarepta May Be The Rarest Of Finds: A ‘Value’ Biotech Stock
May 1, 2017
·
1 min read
Business
M&A Speculation Begins as Sarepta CEO Puts in His Notice
April 28, 2017
·
2 min read
Business
Sarepta CEO Gives CMO Role to Former Amgen-Regeneron Alum
April 4, 2017
·
3 min read
Deals
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million
February 21, 2017
·
2 min read
FDA
Sarepta Under Pressure As Marathon Pharma Emflaza’s Wins FDA Approval for DMD
February 10, 2017
·
3 min read
Genetown
JPM17: Sarepta’s New Numbers Impress Investors, Stock Gained $300 Million Overnight
January 11, 2017
·
2 min read
Deals
With Donald Trump as President, Here’s What Biotech M&A and Drug Pricing Could Look Like (and Renewed Takeover Interest for Tesaro and Sarepta
November 11, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Sarepta Announces Approval to Begin ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
November 26, 2025
·
12 min read
Press Releases
Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
November 24, 2025
·
4 min read
Press Releases
Sarepta Provides Progress Update for SRP-1003, its Investigational siRNA treatment for Myotonic Dystrophy Type 1
November 24, 2025
·
4 min read
Press Releases
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 17, 2025
·
3 min read
Press Releases
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
November 17, 2025
·
10 min read
Press Releases
Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE
November 3, 2025
·
19 min read
Press Releases
Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results
October 28, 2025
·
1 min read
Press Releases
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress
October 6, 2025
·
16 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2025
October 1, 2025
·
1 min read
Press Releases
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
September 8, 2025
·
4 min read
